700 related articles for article (PubMed ID: 18396377)
1. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid.
Schneider T; Roman A; Basta-Kaim A; Kubera M; Budziszewska B; Schneider K; Przewłocki R
Psychoneuroendocrinology; 2008 Jul; 33(6):728-40. PubMed ID: 18396377
[TBL] [Abstract][Full Text] [Related]
2. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters.
Bambini-Junior V; Rodrigues L; Behr GA; Moreira JC; Riesgo R; Gottfried C
Brain Res; 2011 Aug; 1408():8-16. PubMed ID: 21767826
[TBL] [Abstract][Full Text] [Related]
3. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.
Schneider T; Przewłocki R
Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991
[TBL] [Abstract][Full Text] [Related]
4. Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat.
Narita M; Oyabu A; Imura Y; Kamada N; Yokoyama T; Tano K; Uchida A; Narita N
Neurosci Res; 2010 Jan; 66(1):2-6. PubMed ID: 19755133
[TBL] [Abstract][Full Text] [Related]
5. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.
Kim KC; Kim P; Go HS; Choi CS; Park JH; Kim HJ; Jeon SJ; Dela Pena IC; Han SH; Cheong JH; Ryu JH; Shin CY
J Neurochem; 2013 Mar; 124(6):832-43. PubMed ID: 23311691
[TBL] [Abstract][Full Text] [Related]
6. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism.
Schneider T; Turczak J; Przewłocki R
Neuropsychopharmacology; 2006 Jan; 31(1):36-46. PubMed ID: 15920505
[TBL] [Abstract][Full Text] [Related]
7. Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism.
Edalatmanesh MA; Nikfarjam H; Vafaee F; Moghadas M
Brain Res; 2013 Aug; 1526():15-25. PubMed ID: 23806776
[TBL] [Abstract][Full Text] [Related]
8. Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats.
Fisher JE; Acuff-Smith KD; Schilling MA; Nau H; Vorhees CV
Teratology; 1994 Jun; 49(6):479-86. PubMed ID: 7747269
[TBL] [Abstract][Full Text] [Related]
9. Prenatal pregabalin is associated with sex-dependent alterations in some behavioral parameters in valproic acid-induced autism in rat offspring.
Shamsi Meymandi M; Sepehri G; Moslemizadeh A; Vakili Shahrbabaki S; Bashiri H
Int J Dev Neurosci; 2020 Oct; 80(6):500-511. PubMed ID: 32588482
[TBL] [Abstract][Full Text] [Related]
10. Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism.
Codagnone MG; Podestá MF; Uccelli NA; Reinés A
Dev Neurosci; 2015; 37(3):215-31. PubMed ID: 25895486
[TBL] [Abstract][Full Text] [Related]
11. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
12. Tactile stimulation improves neuroanatomical pathology but not behavior in rats prenatally exposed to valproic acid.
Raza S; Harker A; Richards S; Kolb B; Gibb R
Behav Brain Res; 2015 Apr; 282():25-36. PubMed ID: 25557797
[TBL] [Abstract][Full Text] [Related]
13. Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus.
Bristot Silvestrin R; Bambini-Junior V; Galland F; Daniele Bobermim L; Quincozes-Santos A; Torres Abib R; Zanotto C; Batassini C; Brolese G; Gonçalves CA; Riesgo R; Gottfried C
Brain Res; 2013 Feb; 1495():52-60. PubMed ID: 23219577
[TBL] [Abstract][Full Text] [Related]
14. Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism.
Tsujino N; Nakatani Y; Seki Y; Nakasato A; Nakamura M; Sugawara M; Arita H
Neurosci Res; 2007 Feb; 57(2):289-95. PubMed ID: 17157402
[TBL] [Abstract][Full Text] [Related]
15. In utero exposure to valproic acid and autism--a current review of clinical and animal studies.
Roullet FI; Lai JK; Foster JA
Neurotoxicol Teratol; 2013; 36():47-56. PubMed ID: 23395807
[TBL] [Abstract][Full Text] [Related]
16. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
[TBL] [Abstract][Full Text] [Related]
17. Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
Foley AG; Cassidy AW; Regan CM
Eur J Pharmacol; 2014 Mar; 727():80-6. PubMed ID: 24486700
[TBL] [Abstract][Full Text] [Related]
18. Persisting behavioral consequences of prenatal domoic acid exposure in rats.
Levin ED; Pizarro K; Pang WG; Harrison J; Ramsdell JS
Neurotoxicol Teratol; 2005; 27(5):719-25. PubMed ID: 16054336
[TBL] [Abstract][Full Text] [Related]
19. Effects of prenatal exposure to valproic acid on the development of juvenile-typical social play in rats.
Raza S; Himmler BT; Himmler SM; Harker A; Kolb B; Pellis SM; Gibb R
Behav Pharmacol; 2015 Dec; 26(8 Spec No):707-19. PubMed ID: 26230723
[TBL] [Abstract][Full Text] [Related]
20. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
